SCHEMBL23958175

SCHEMBL23958175

COc1ccncc1Nc1nc2ccc(Cl)cc2c(=O)n1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.45
TP53 P04637 1/20 0.45
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAT2A P31153 1/20 0.42
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41
TUBB2A Q13885 1/20 0.41
TUBB8 Q3ZCM7 1/20 0.41
TUBA3E Q6PEY2 1/20 0.41
TUBA1A Q71U36 1/20 0.41
TUBA1C Q9BQE3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23958263 0.88 NPC1 (0.43) MAPTKDM4EPOLBMAT2ATUBB4A
SCHEMBL24110954 0.83 TUBB4A (0.41) TP53KDM4ESMN1; SMN2MAT2ATUBB4A
SCHEMBL29623403 0.83 PI4KA (0.46) MAPTTP53KDM4EALDH1A1POLB
SCHEMBL23064701 0.83 PI4KA (0.46) MAPTTP53KDM4EALDH1A1POLB
SCHEMBL30103257 0.82 MAT2A (0.47) MAPTTP53SMN1; SMN2MAT2ATUBB4A
SCHEMBL24110970 0.82 MAT2A (0.47) MAPTTP53SMN1; SMN2MAT2ATUBB4A
SCHEMBL23958260 0.81 PI4KA (0.46) MAPTTP53KDM4EALDH1A1POLB
SCHEMBL23064704 0.81 PDE10A (0.47) MAPTTP53SMN1; SMN2P2RX7
SCHEMBL29623176 0.81 PDE10A (0.47) MAPTTP53SMN1; SMN2P2RX7
SCHEMBL23958280 0.81 TUBB4A (0.47) KDM4ESMN1; SMN2TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 MAPT 4749/4885TP53 3842/4885KDM4E 1401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.